Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Interest in how the gut microbiome can influence the metabolic state of the host has recently heightened. One postulated link is bacterial fermentation of “indigestible” prebiotics to short-chain fatty acids (SCFAs), which in turn modulate the release of gut hormones controlling insulin release and appetite. We show here that SCFAs trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 from mixed colonic cultures in vitro. Quantitative PCR revealed enriched expression of the SCFA receptors ffar2 (grp43) and ffar3 (gpr41) in GLP-1–secreting L cells, and consistent with the reported coupling of GPR43 to Gq signaling pathways, SCFAs raised cytosolic Ca2+ in L cells in primary culture. Mice lacking ffar2 or ffar3 exhibited reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and a parallel impairment of glucose tolerance. These results highlight SCFAs and their receptors as potential targets for the treatment of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2. SCFAs raise intracellular calcium in identified colonic L cells. A: Mixed colonic cultures were loaded with fura2-AM. Pseudocolor images of fura2 340:380 nm fluorescence ratio (reflecting [Ca2+]i) shown prior to (basal) and during the application of propionate (1 mmol/L), and after washing with saline. B: Identification of an L cell in the field of view shown in A identified by the fluorescence of Venus (475 nm excitation). C: A representative response of an L and a non–L cell recorded as in A. D: Mean calcium changes in L cells (filled bars) and non–L cells (open bars) after the addition of acetate (1 mmol/L), propionate (1 mmol/L), or CFMB (30 μmol/L) as indicated. Ratios (340:380) in the presence of the test agent were normalized to the mean of the background ratios of each cell measured before addition and after washout of the test compound. Data represent the means ± SEM of the number of cells indicated above each bar. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with baseline and ##P < 0.01 and ###P < 0.001 compared with non–L cells by Student t test. (A high-quality digital representation of this figure is available in the online issue.)](https://figures.cochat.ai/paper-figures/c242c8ac43cc4c669f03082b05300a60/short-chain-fatty-acids-stimulate-glucagon-like-peptide-1-secretion-via-the-g-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFA-induced activation of receptors on enteroendocrine cells can promote gut-brain signaling by inducing hormones such as glucagon-like peptide 1 (GLP1) and peptide YY (PYY), as well as neurotransmitters like GABA and serotonin (276).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [276]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rodent-based studies also suggest that SCFAs may influence gut motility [57], suppress appetite (through enhanced incretin [glucagon-like peptide-1, GLP-1] release) and enhance insulin sensitivity [58].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in rodents show that the administration of prebiotics that influences a shift in the gut microbiome toward increased production of butyrate has beneficial effects associated with higher levels of GLP-1 (193–195), as well as hypothalamic expression of pro-opiomelanocortin (196), thereby influencing the hunger-satiety cycle.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [193]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs can stimulate the secretion of GLP-1 and PYY through the FFAR2 and, to a lesser extent, the FFAR3 receptor (Lin et al., 2012;Psichas et al., 2015;Tolhurst et al., 2012).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Tolhurst et al., 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, SCFA can stimulate the release of GLP-1 in vitro and in vivo dependently of the FFA receptor 2 (Figure 1) [237].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [237]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564
Glucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 8×
“Secreted and cellular GLP-1 was extracted as previously described (24), and active GLP-1 was quantified by ELISA (Millipore).”
MethodInfluentialSelf-citationXiong, Y., Miyamoto, N., Shibata, K., Valasek, M. A., Motoike, T., Kedzierski, R. M., & Yanagisawa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2637002100 · Cited by 731
Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654
Acetate and Propionate Short Chain Fatty Acids Stimulate Adipogenesis via GPCR43
Hong, Y.-H., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., Choi, K.-C., Feng, D. D., Chen, C., Lee, H.-G., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0545 · Cited by 612
Cited by
Items 501–600 of 1,015
Pharmacology and physiology of gastrointestinal enteroendocrine cells
Mace, O. J., Tehan, B., & Marshall, F. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.155 · Cited by 91
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Paternoster, S., & Falasca, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00584 · Cited by 91
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 98
Vitale, M., Giacco, R., Laiola, M., Pepa, G. D., Luongo, D., Mangione, A., Salamone, D., Vitaglione, P., Ercolini, D., & Rivellese, A. A. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.025 · Cited by 96
Interactions between the microbiota and enteric nervous system during gut-brain disorders
Fried, S. G., Wemelle, E., Cani, P. D., & Knauf, C. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108721 · Cited by 102
Zádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 98
Moțățăianu, A., Şerban, G. M., & Andone, S. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015094 · Cited by 100
Enteroendocrine cell regulation of the gut-brain axis
Barton, J. R., Londregan, A., Alexander, T. D., Entezari, A. A., Covarrubias, M., & Waldman, S. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1272955 · Cited by 102
Microbiome Gut-Brain-Axis: Impact on Brain Development and Mental Health
Ramadan, Y. N., Alqifari, S. F., Alshehri, K., Alhowiti, A., Mirghani, H. O., Alrasheed, T., Aljohani, F., Alghamdi, A. M., & Hetta, H. F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04846-0 · Cited by 110
Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
Mishima, Y., & Ishihara, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228664 · Cited by 99
The Emerging Role of Polyphenols in the Management of Type 2 Diabetes
Wang, Y., Alkhalidy, H., & Liu, D. (2021) · Molecules · doi:10.3390/molecules26030703 · Cited by 88
Molecular mechanisms of incretin hormone secretion
Ezcurra, M., Reimann, F., Gribble, F. M., & Emery, E. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.013 · Cited by 88
Self-citationTreatment of Type 2 Diabetes by Free Fatty Acid Receptor Agonists
Watterson, K. R., Hudson, B. D., Ulven, T., & Milligan, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00137 · Cited by 97
The microbiota-gut-brain axis: Focus on the fundamental communication pathways
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 88
Oral Microalgae-Nano Integrated System against Radiation-Induced Injury
Zhang, D., He, J., Cui, J., Wang, R., Tang, Z., Yu, H., & Zhou, M. (2023) · ACS Nano · doi:10.1021/acsnano.3c01502 · Cited by 90
Jayakumar, S., & Loomba, R. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15314 · Cited by 84
The short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis
Fuller, M. H., Priyadarshini, M., Gibbons, S. M., Angueira, A. R., Brodsky, M. R., Hayes, M. G., Kovatcheva‐Datchary, P., Bäckhed, F., Gilbert, J. A., Lowe, W. L., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00171.2015 · Cited by 103
Sandberg, J. C., Björck, I., & Nilsson, A. C. (2017) · Nutrition Journal · doi:10.1186/s12937-017-0246-5 · Cited by 99
Berding, K., Long-Smith, C., Carbia, C., Bastiaanssen, T., van de Wouw, M., Wiley, N., Strain, C., Fouhy, F., Stanton, C., Cryan, J., et al. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05665-y
Li, X., He, M., Yi, X., Lu, X., Zhu, M., Xue, M., Tang, Y., & Zhu, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26991 · Cited by 100
Gut Microbiota as an Endocrine Organ: Unveiling Its Role in Human Physiology and Health
Pires, L., Gonzaléz‐Paramás, A. M., Heleno, S. A., & Calhelha, R. C. (2024) · Applied Sciences · doi:10.3390/app14209383 · Cited by 94
Gut microbiome differences between metformin‐ and liraglutide‐treated T2 DM subjects
Wang, Z., Saha, S., Van Horn, S., Thomas, E., Traini, C., Sathe, G., Rajpal, D. K., & Brown, J. R. (2018) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.9 · Cited by 82
Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD)
Yoo, J. Y., Sniffen, S. E., Percy, K. C. M., Chidipi, B., & Pallaval, V. B. (2022) · Microorganisms · doi:10.3390/microorganisms10010108 · Cited by 96
Xu, M., Lan, R., Qiao, L., Lin, X., Hu, D., Zhang, S., Yang, H. J., Zhou, J., Ren, Z., Li, X., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02517-22 · Cited by 101
Obesity and Asthma: Microbiome–Metabolome Interactions
Shore, S. A., & Cho, Y. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0052ps · Cited by 90
Xu, J. H., Liu, X. Z., Pan, W., & Zou, D. J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6321 · Cited by 86
Gut microbiota, hypertension and chronic kidney disease: Recent advances
Sircana, A., Michieli, F. D., Parente, R., Framarin, L., Leone, N., Berrutti, M., Paschetta, E., Bongiovanni, D., & Musso, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.013 · Cited by 96
Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology
Engevik, M. A., & Versalovic, J. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0012-2016 · Cited by 98
Peng, L., Zhang, Q., Zhang, Y., Yao, Z., Song, P., Wei, L., Zhao, G., & Yan, Z. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1291 · Cited by 87
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
Thulasinathan, B., Suvilesh, K. N., Maram, S., Grossmann, E. M., Ghouri, Y. A., Teixeiro, E., Chan, J., Kaifi, J. T., & Rachagani, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2483780 · Cited by 92
Role of nutrient-sensing taste 1 receptor (T1R) family members in gastrointestinal chemosensing
Shirazi‐Beechey, S. P., Daly, K., Al-Rammahi, M. A., Moran, A. W., & Bravo, D. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513002286 · Cited by 90
Raza, G. S., Putaala, H., Hibberd, A. A., Alhoniemi, E., Tiihonen, K., Mäkelä, K. A., & Herzig, K.-H. (2017) · Scientific Reports · doi:10.1038/s41598-017-05259-3 · Cited by 83
Synbiotics for Improved Human Health: Recent Developments, Challenges, and Opportunities
Krumbeck, J. A., Walter, J., & Hutkins, R. W. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030117-012757 · Cited by 84
Ducastel, S., Touche, V., Trabelsi, M.-S., Boulinguiez, A., Butruille, L., Nawrot, M., Peschard, S., Chávez-Talavera, O., Dorchies, E., Vallez, E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-56743-x · Cited by 84
Matsumoto, K., Ichimura, M., Tsuneyama, K., Moritoki, Y., Tsunashima, H., Omagari, K., Hara, M., Yasuda, I., Miyakawa, H., & Kikuchi, K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175406 · Cited by 84
Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease
Cantu-Jungles, T. M., Rasmussen, H. E., & Hamaker, B. R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00663 · Cited by 81
Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?
Martín‐Núñez, G. M., Cornejo-Pareja, I. M., Clemente‐Postigo, M., & Tinahones, F. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639856 · Cited by 96
Metabolic and functional interplay between gut microbiota and fat-soluble vitamins
Stacchiotti, V., Rezzi, S., Eggersdorfer, M. L., & Galli, F. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1793728 · Cited by 89
Yang, Q., Ouyang, J., Sun, F., & Yang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590685 · Cited by 90
Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
Liu, M., Nieuwdorp, M., de Vos, W. M., & Rampanelli, E. (2022) · Metabolites · doi:10.3390/metabo12090834 · Cited by 94
Pedersen, C., Lefevre, S., Peters, V., Patterson, M., Ghatei, M. A., Morgan, L., & Frost, G. S. (2013) · Appetite · doi:10.1016/j.appet.2013.02.017 · Cited by 96
In vitro modulation of gut microbiota by whey protein to preserve intestinal health
Sánchez‐Moya, T., López‐Nicolás, R., Planes-Muñoz, D., González‐Bermúdez, C. A., Ros, G., & Frontela‐Saseta, C. (2017) · Food & Function · doi:10.1039/c7fo00197e · Cited by 89
Satiety: a gut–brain–relationship
Barakat, G. M., Ramadan, W., Assi, G., & Khoury, N. B. E. (2024) · The Journal of Physiological Sciences · doi:10.1186/s12576-024-00904-9 · Cited by 82
“Hence, the interaction of bacterial metabolites like propionate with intestinal L-cells can directly control GLP-1 production [42].”
BackgroundProbiotics for the treatment of type 2 diabetes: A review of randomized controlled trials
Tiderencel, K. A., Hutcheon, D. A., & Ziegler, J. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3213 · Cited by 82
Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice
Pierre, J. F., Martinez, K. B., Ye, H., Nadimpalli, A., Morton, T. C., Yang, J., Wang, Q., Patno, N., Chang, E. B., & Yin, D. P. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00202.2016 · Cited by 82
Leveraging the Gut to Treat Metabolic Disease
Gimeno, R. E., Briere, D. A., & Seeley, R. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.014 · Cited by 83
The Role of the Gut Microbiota in the Gut–Brain Axis in Obesity: Mechanisms and Future Implications
van Son, J., Koekkoek, L. L., la Fleur, S. E., Serlie, M. J. M., & Nieuwdorp, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062993 · Cited by 91
Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study
Du, Y., Zhu, Y., Zhou, Y., Ding, J., & Liu, J. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00108-w · Cited by 96
Our extended microbiome: The human-relevant metabolites and biology of fermented foods
Caffrey, E. B., Sonnenburg, J. L., & Devkota, S. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.007 · Cited by 89
Rebello, C. J., Burton, J., Heiman, M., & Greenway, F. L. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.08.023 · Cited by 81
Forbes, S., Stafford, S., Coope, G., Heffron, H., Real, K., Newman, R., Davenport, R., Barnes, M., Grosse, J., & Cox, H. (2015) · Diabetes · doi:10.2337/db15-0481 · Cited by 82
Self-citationAdam, C. L., Williams, P. A. H., Garden, K. E., Thomson, L. M., & Ross, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115438 · Cited by 82
Potential mediators linking gut bacteria to metabolic health: a critical view
Janssen, A. W. F., & Kersten, S. (2017) · The Journal of Physiology · doi:10.1113/jp272476 · Cited by 82
Lund, M. L., Sorrentino, G., Egerod, K. L., Kroone, C., Mortensen, B., Knop, F. K., Reimann, F., Gribble, F. M., Drucker, D. J., de Koning, E. J. P., et al. (2020) · Diabetes · doi:10.2337/db19-0764 · Cited by 82
Self-citationRoles for the gut microbiota in regulating neuronal feeding circuits
Yu, K. B., & Hsiao, E. Y. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143772 · Cited by 88
Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 99
Fang, H., Lacerda, R. R. E., Barra, N. G., Zada, D. K., Robin, N., Mehra, A., & Schertzer, J. D. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae025 · Cited by 97
Barrea, L., Muscogiuri, G., Annunziata, G., Laudisio, D., Pugliese, G., Salzano, C., Colao, A., & Savastano, S. (2019) · Hormones · doi:10.1007/s42000-019-00100-0 · Cited by 81
Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis
Goudman, L., Demuyser, T., Pilitsis, J. G., Billot, M., Roulaud, M., Rigoard, P., & Moens, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1342833 · Cited by 82
Mikkelsen, K. H., Allin, K. H., & Knop, F. K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12637 · Cited by 80
Ding, Q., Zhang, B., Zheng, W., Chen, X., Zhang, J., Yan, R.-Y., Zhang, T., Yu, L., Dong, Y., & Ma, B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109262 · Cited by 81
Intestinal microbial metabolites in human metabolism and type 2 diabetes
Herrema, H., & Niess, J. H. (2020) · Diabetologia · doi:10.1007/s00125-020-05268-4 · Cited by 86
What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?
Kuhre, R. E., Deacon, C. F., Holst, J. J., & Petersen, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.694284 · Cited by 78
Biological factors controlling starch digestibility in human digestive system
Li, C., Hu, Y., Li, S., Yi, X., Shao, S., Yu, W., & Li, E. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.07.037 · Cited by 82
Jameson, K. G., Kazmi, S. A., Ohara, T. E., Son, C., Yu, K. B., Mazdeyasnan, D., Leshan, E., Vuong, H. E., Paramo, J., Lopez-Romero, A., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111699 · Cited by 96
Steensels, S., & Depoortere, I. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121332 · Cited by 78
Han, L., Li, T., Du, ., Chang, R., Zhan, B., & Mao, X. (2019) · Nutrients · doi:10.3390/nu11030670 · Cited by 82
Targeting Carbohydrates and Polyphenols for a Healthy Microbiome and Healthy Weight
Hul, M. V., & Cani, P. D. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00281-5 · Cited by 85
Sivaprakasam, S., Bhutia, Y., Ramachandran, S., & Ganapathy, V. (2017) · Nutrients · doi:10.3390/nu9080856 · Cited by 79
Free Fatty Acid Receptors in Enteroendocrine Cells
Lu, V. B., Gribble, F. M., & Reimann, F. (2018) · Endocrinology · doi:10.1210/en.2018-00261 · Cited by 76
Self-citationGuo, X., Lv, J., & Xi, R. (2021) · FEBS Journal · doi:10.1111/febs.16067 · Cited by 88
A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias
Bolognini, D., Hodge, D., Nilsson, K. A., Petersson, A., Donnelly, I., Sergeev, E., König, G. M., Kostenis, E., Kurowska‐Stolarska, M., Miller, A. M., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.736157 · Cited by 86
Holdemanella biformis improves glucose tolerance and regulates GLP‐1 signaling in obese mice
Romaní‐Pérez, M., López‐Almela, I., Bullich‐Vilarrubias, C., Rueda‐Ruzafa, L., del Pulgar, E. M. G., Benítez‐Páez, A., Liebisch, G., Lamas, J. A., & Sanz, Y. (2021) · The FASEB Journal · doi:10.1096/fj.202100126r · Cited by 83
Homeostasis in the Gut Microbiota in Chronic Kidney Disease
Bhargava, S., Merckelbach, E., Noels, H., Vohra, A., & Jankowski, J. (2022) · Toxins · doi:10.3390/toxins14100648 · Cited by 88
Song, X., Liu, Y., Zhang, X., Weng, P., Zhang, R., & Wu, Z. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.02.005 · Cited by 87
Lu, R., Meng, H., Gao, X., Xu, L., & Feng, X. (2013) · Journal of Periodontal Research · doi:10.1111/jre.12137 · Cited by 79
Mandøe, M. J., Hansen, K. B., Hartmann, B., Rehfeld, J. F., Holst, J. J., & Hansen, H. S. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.106799 · Cited by 81
Federico, A., Dallio, M., Tolone, S., Gravina, A. G., Patrone, V., Romano, M., Tuccillo, C., Mozzillo, A. L., Amoroso, V., Misso, G., et al. (2016) · PubMed · Cited by 92
Sun, Y., Jin, C., Zhang, X., Jia, W., Le, J., & Ye, J. (2018) · Nutrition & Diabetes · doi:10.1038/s41387-018-0061-x · Cited by 76
Kundi, Z. M., Lee, J. C., Pihlajamäki, J., Chan, C. B., Leung, K. S., So, S. S. Y., Nordlund, E., Kolehmainen, M., & El-Nezami, H. S. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900580 · Cited by 88
Lee, H., An, J., Kim, J., Choi, D., Song, Y., Lee, C., Kong, H., Kim, S. B., & Kim, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.858192 · Cited by 82
Modulation of the Gut Microbiota by Nutrition and Its Relationship to Epigenetics
Ferenc, K., Sokal-Dembowska, A., Helma, K., Motyka, E., Jarmakiewicz-Czaja, S., & Filip, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021228 · Cited by 84
Beneficial Effects of Korean Traditional Diets in Hypertensive and Type 2 Diabetic Patients
Jung, S., Park, S., Choi, E.-K., Cha, Y., Cho, B.-H., Kim, Y.-G., Kim, M., Song, W. O., Park, T.-S., Ko, J., et al. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.3042 · Cited by 81
Microbial regulation of the L cell transcriptome
Arora, T., Akrami, R., Pais, R., Bergqvist, L., Johansson, B. R., Schwartz, T. W., Reimann, F., Gribble, F. M., & Bäckhed, F. (2018) · Scientific Reports · doi:10.1038/s41598-017-18079-2 · Cited by 74
Self-citationCanfora, E. E., & Blaak, E. E. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000408 · Cited by 76
Regulation of endocrine systems by the microbiome: Perspectives from comparative animal models
Williams, C. L., García‐Reyero, N., Martyniuk, C. J., Tubbs, C. W., & Bisesi, J. H. (2020) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2020.113437 · Cited by 79
Tang, X., & de Vos, P. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2290230 · Cited by 82
Li, L., Krause, L., & Somerset, S. M. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.06.029 · Cited by 82
Gut Microbiota: Modulation of Host Physiology in Obesity
Nehra, V., Allen, J. M., Mailing, L. J., Kashyap, P. C., & Woods, J. A. (2016) · Physiology · doi:10.1152/physiol.00005.2016 · Cited by 73
Adachi, K., Sugiyama, T., Yamaguchi, Y., Tamura, Y., Izawa, S., Hijikata, Y., Ebi, M., Funaki, Y., Ogasawara, N., Goto, C., et al. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-101 · Cited by 70
Fujisaka, S., Usui, I., Nawaz, A., Igarashi, Y., Okabe, K., Furusawa, Y., Watanabe, S., Yamamoto, S., Sasahara, M., Watanabe, Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62506-w · Cited by 79
The Role of the Gut Microbiota in Coronary Heart Disease
Liu, H., Zhuang, J., Tang, P., Li, J., Xiong, X., & Deng, H. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00892-2 · Cited by 82
Chandramowlishwaran, P., Vijay, A., Abraham, D., Li, G., Mwangi, S. M., & Srinivasan, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614331 · Cited by 77
Dietary Influences on the Microbiota–Gut–Brain Axis
Barber, T. M., Valsamakis, G., Mastorakos, G. P., Hanson, P., Kyrou, I., Randeva, H. S., & Weickert, M. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073502 · Cited by 84
Xie, C., Qi, C., Zhang, J., Wang, W., Meng, X., Aikepaer, A., Lin, Y., Su, C., Liu, Y., Feng, X., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116791 · Cited by 76
The effects of short-chain fatty acids on the cardiovascular system
Richards, L. B., Li, M., van Esch, B. C. A. M., Garssen, J., & Folkerts, G. (2016) · PharmaNutrition · doi:10.1016/j.phanu.2016.02.001 · Cited by 81
Effects of oral florfenicol and azithromycin on gut microbiota and adipogenesis in mice
Li, R., Wang, H., Shi, Q., Wang, N., Zhang, Z., Xiong, C., Liu, J., Chen, Y., Jiang, L., & Jiang, Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181690 · Cited by 85
The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
Hjørne, A. P., Modvig, I. M., & Holst, J. J. (2022) · Metabolites · doi:10.3390/metabo12050420 · Cited by 71
Gut microbiota mediated hypoglycemic effect of Astragalus membranaceus polysaccharides in db/db mice
Song, Q., Cheng, S. W., Li, D., Cheng, H., Lai, Y. S., Han, Q., Wu, H. Y., Shaw, P. C., & Zuo, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043527 · Cited by 74
Sonne, D. P., Hansen, M., & Knop, F. K. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0154 · Cited by 75
Metadata
- Authors
- Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M.
- Affiliations
- Addenbrooke's Hospital (GB)
- Takeda (United Kingdom) (GB)
- Corresponding author
- Reimann, Frank
- Gribble, Fiona M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-01-17
- Volume
- 61
- Issue
- 2
- Pages
- 364-371
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3266401
- OpenAlex
- W2168842536
- Cited by
- 2,404
- References
- 32
- Citations by year
- 2026: 266 · 2025: 233 · 2024: 203 · 2023: 183 · 2022: 245 · 2021: 205 · 2020: 215 · 2019: 151 · 2018: 158 · 2017: 120 · 2016: 132 · 2015: 103 · 2014: 92 · 2013: 65 · 2012: 27
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
- Apollo
- Funders
- Wellcome Trust (084210/Z/07/Z, 088357/Z/09/Z, #WT084210, 088357, 088357/Z/09/A)
- European Commission (2007–2013, 266408)
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short-chain fatty acids, glucagon-like peptide-1, FFAR2, GPR43, GPR41, incretin secretion, gut microbiota, prebiotic fermentation, colonic epithelial cells, calcium signaling, glucose tolerance, diabetes treatment, Gq signaling
- MeSH terms
- Animals, Calcium, Colon, Fatty Acids, Volatile, Mice, Inbred C57BL, Signal Transduction, GTP-Binding Protein alpha Subunits, Gi-Go, Receptors, G-Protein-Coupled, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.